Cargando…

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome

OBJECTIVE: A pilot open label, single dose trial of fenobam, an mGluR5 antagonist, was conducted to provide an initial evaluation of safety and pharmacokinetics in adult males and females with fragile X syndrome (FXS). METHODS: Twelve subjects, recruited from two fragile X clinics, received a single...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berry-Kravis, E, Hessl, D, Coffey, S, Hervey, C, Schneider, A, Yuhas, J, Hutchison, J, Snape, M, Tranfaglia, M, Nguyen, D V, Hagerman, R
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2009
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658751/ https://www.ncbi.nlm.nih.gov/pubmed/19126569 http://dx.doi.org/10.1136/jmg.2008.063701

Ejemplares similares

Open-label add-on treatment trial of minocycline in fragile X syndrome
por: Paribello, Carlo, et al.
Publicado: (2010)

Reliability of Eye Tracking and Pupillometry Measures in Individuals with Fragile X Syndrome
por: Farzin, Faraz, et al.
Publicado: (2011)

Feasibility, reliability, and clinical validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X syndrome (FXS)
por: Knox, Andrew, et al.
Publicado: (2012)

Targeted treatments for fragile X syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2011)

Aging in fragile X syndrome
por: Utari, Agustini, et al.
Publicado: (2010)

Effects of mavoglurant on visual attention and pupil reactivity while viewing photographs of faces in Fragile X Syndrome
por: Hessl, David, et al.
Publicado: (2019)

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents
por: Hagerman, Randi, et al.
Publicado: (2018)

Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X Syndrome
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2012)

Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS)
por: Hall, Deborah A., et al.
Publicado: (2020)

Response to Placebo in Fragile X Syndrome Clinical Trials: An Initial Analysis
por: Luu, Skylar, et al.
Publicado: (2020)

Best Practices in Fragile X Syndrome Treatment Development
por: Erickson, Craig A., et al.
Publicado: (2018)

Voice of People with Fragile X Syndrome and Their Families: Reports from a Survey on Treatment Priorities
por: Weber, Jayne Dixon, et al.
Publicado: (2019)

Fragile X targeted pharmacotherapy: lessons learned and future directions
por: Erickson, Craig A., et al.
Publicado: (2017)

Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization
por: Cordeiro, Lisa, et al.
Publicado: (2010)

Brief Report: Sensorimotor Gating in Idiopathic Autism and Autism Associated with Fragile X Syndrome
por: Yuhas, Jennifer, et al.
Publicado: (2010)

The challenges of clinical trials in fragile X syndrome
por: Jacquemont, Sébastien, et al.
Publicado: (2013)

Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems
por: Hagerman, Randi J, et al.
Publicado: (2008)

Reversal of Fragile X Phenotypes by Manipulation of AβPP/Aβ Levels in Fmr1(KO) Mice
por: Westmark, Cara J., et al.
Publicado: (2011)

Fragile X Premutation
por: Tassone, Flora, et al.
Publicado: (2014)

Neuropsychological changes in FMR1 premutation carriers and onset of fragile X-associated tremor/ataxia syndrome
por: Famula, Jessica, et al.
Publicado: (2022)

Clinical and molecular correlates in fragile X premutation females
por: Jiraanont, Poonnada, et al.
Publicado: (2017)

Autoimmune disease in mothers with the FMR1 premutation is associated with seizures in their children with fragile X syndrome
por: Chonchaiya, Weerasak, et al.
Publicado: (2010)

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome
por: Budimirovic, Dejan B., et al.
Publicado: (2017)

Observable Symptoms of Anxiety in Individuals with Fragile X Syndrome: Parent and Caregiver Perspectives
por: Lozano, Reymundo, et al.
Publicado: (2022)

Arbaclofen in fragile X syndrome: results of phase 3 trials
por: Berry-Kravis, Elizabeth, et al.
Publicado: (2017)

Fragile X-Associated Neuropsychiatric Disorders (FXAND) in Young Fragile X Premutation Carriers
por: Aishworiya, Ramkumar, et al.
Publicado: (2022)

Preclinical and translational studies of fenobam, an mGlu5 NAM, for the treatment of pain
por: Gereau IV, Robert W, et al.
Publicado: (2014)

A solution to limitations of cognitive testing in children with intellectual disabilities: the case of fragile X syndrome
por: Hessl, David, et al.
Publicado: (2008)

Fragile X syndrome and fragile X-associated disorders
por: Rajaratnam, Akash, et al.
Publicado: (2017)

Clinical and Molecular Correlates of Abnormal Changes in the Cerebellum and Globus Pallidus in Fragile X Premutation
por: Wang, Jun Yi, et al.
Publicado: (2022)

Intercorrelation of Molecular Biomarkers and Clinical Phenotype Measures in Fragile X Syndrome
por: Aishworiya, Ramkumar, et al.
Publicado: (2023)

Fragile X Syndrome
por: McLennan, Yingratana, et al.
Publicado: (2011)

Fragile X-Associated Neuropsychiatric Disorders (FXAND)
por: Hagerman, Randi J., et al.
Publicado: (2018)

Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study
por: Brašić, James Robert, et al.
Publicado: (2022)

Emerging Therapeutic Strategies for Fragile X Syndrome: Q&A
por: Alusi, Ghassan, et al.
Publicado: (2022)

Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers
por: Polussa, Jonathan, et al.
Publicado: (2014)

A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome
por: Lee, Michelle, et al.
Publicado: (2016)

Clinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective
por: Lee, Anna W., et al.
Publicado: (2018)

Soy-Based Infant Formula is Associated with an Increased Prevalence of Comorbidities in Fragile X Syndrome
por: Westmark, Cara J., et al.
Publicado: (2020)

A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome
por: Ligsay, Andrew, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7kjp0h4cghklck0936thb743sc